Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection

Bruk av Ultralyd i Evaluering av Pasienter Med Mistenkt COVID-19 Infeksjon i Norge

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04422691

Acronym

COVIDUS-NOR

Enrollment

Registered

2020-06-09

Start date

2020-07-01

Completion date

2021-06-15

Last updated

2021-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Pneumonia, Viral, Pulmonary Infection

Keywords

Ultrasonography, Norway, Emergency Department, Emergency Physicians

Brief summary

In light of the ongoing COVID-19 epidemic in Norway, it is paramount to develop and utilize clinical tools for assessing and risk stratifying patients with suspected coronary infection in the emergency departments. Diagnostic use of ultrasound in viral pneumonias, including COVID-19 has proved to be very useful. The use of ultrasound will assist in quick detection of lung pathology compatible with increasing severity of the COVID-19 disease. At the same time, the use of ultrasound diagnostics in the emergency department could improve logistics and reduce potential exposure of the corona virus to other health personnel. The purpose of the study is to assess whether ultrasound findings correlates with physical examination, labs, and other imaging diagnostics in patients with suspected or diagnosed COVID-19 disease, as well as assessing whether ultrasound diagnostics can assist in risk stratification. The project is conducted as a prospective multicenter study where ultrasound diagnostics will be performed on patients with suspected coronary infection in the emergency departments. Data collection takes place as part of the daily clinical evaluation of acute patients in the emergency departments. The project is planned to be completed towards the end of 2025.

Interventions

DIAGNOSTIC_TESTLung ultrasound

After verbal consent the enrolled patients' lungs are evaluated with ultrasound while in isolation. The lungs are divided into 3 fields and findings are categorized according to Soldati et al., 2020.

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

17 Years to No maximum

Healthy volunteers

Inclusion criteria

\- All emergency department patients with suspected or diagnosed COVID-19.

Exclusion criteria

* Negative screening for COVID-19 * recent negative COVID-19 test * no indication for isolation in the Emergency Department

Design outcomes

Primary

Measure	Time frame	Description
Level-of-care	up to 7 days	In-hospital treatment level, e.g. discharge from ED, observational unit, ward, ICU.
Mortality	up to 30 days	30-day mortality

Secondary

Measure	Time frame	Description
Oxygen usage in the emergency department	Within 24 hours	—
Antibiotics usage	Within 24 hours	—
Emergency department length of stay	Within 24 hours	in hours
In-hospital length of stay	Up to 30 days	in days

Other

Measure	Time frame	Description
Clinical correlation	Within 3 days	Clinical correlation between ultrasound findings and vital signs, labs, blood gas and other diagnostic modalities.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026